LC-MS profiling of N-glycans derived from human serum samples for biomarker discovery in hepatocellular carcinoma

Journal of Proteome Research

Volumn 13, Issue 11, 2014, Pages 4859-4868

  Tsai, Tsung Heng ^a   Wang, Minkun ^a   Di Poto, Cristina ^a   Hu, Yunli ^b   Zhou, Shiyue ^b   Zhao, Yi ^a   Varghese, Rency S ^a   Luo, Yue ^a   Tadesse, Mahlet G ^c   Ziada, Dina Hazem ^d   Desai, Chirag S ^e   Shetty, Kirti ^e   Mechref, Yehia ^b   Ressom, Habtom W ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b TEXAS TECH UNIVERSITY   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

^d TANTA UNIVERSITY   (Egypt)

^e GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

cancer biomarker discovery; glycomics; hepatocellular carcinoma; liver cirrhosis; mass spectrometry; multiple reaction monitoring

Indexed keywords

GLYCAN DERIVATIVE; PLASMA PROTEIN; TUMOR MARKER; POLYSACCHARIDE;

ARTICLE; BLOOD SAMPLING; CANCER GROWTH; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; LIQUID CHROMATOGRAPHY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; BLOOD; CARCINOMA, HEPATOCELLULAR; COMPARATIVE STUDY; COMPLICATION; EGYPT; GENE EXPRESSION PROFILING; LIVER NEOPLASMS; MASS SPECTROMETRY; PROCEDURES; UNITED STATES;

BIOMARKERS, TUMOR; CARCINOMA, HEPATOCELLULAR; CHROMATOGRAPHY, LIQUID; EGYPT; GENE EXPRESSION PROFILING; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MASS SPECTROMETRY; POLYSACCHARIDES; UNITED STATES;

EID: 84908884009     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr500460k     Document Type: Article

References (41)

1. Ferlay, J.; Shin, H. R.; Bray, F.; Forman, D.; Mathers, C.; Parkin, D. M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int. J. Cancer 2010, 127 (12) 2893-2917
2. Arzumanyan, A.; Reis, H. M.; Feitelson, M. A. Pathogenic mechanisms in HBV-and HCV-associated hepatocellular carcinoma Nat. Rev. Cancer 2013, 13 (2) 123-135
3. Center, M.; Siegel, R.; Jemal, A. Global Cancer Facts & Figures; American Cancer Society: Atlanta, GA. 2011.
4. El-Serag, H. B. Hepatocellular carcinoma N. Engl. J. Med. 2011, 365 (12) 1118-1127
5. Bialecki, E. S.; Di Bisceglie, A. M. Diagnosis of hepatocellular carcinoma HPB (Oxford) 2005, 7 (1) 26-34
6. Trevisani, F.; DIntino, P. E.; Morselli-Labate, A. M.; Mazzella, G.; Accogli, E.; Caraceni, P.; Domenicali, M.; De Notariis, S.; Roda, E.; Bernardi, M. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: Influence of HBsAg and anti-HCV status J. Hepatol. 2001, 34 (4) 570-575
7. Gupta, S.; Bent, S.; Kohlwes, J. Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis Ann. Int. Med. 2003, 139 (1) 46-50
8. Fuster, M. M.; Esko, J. D. The sweet and sour of cancer: Glycans as novel therapeutic targets Nat. Rev. Cancer 2005, 5 (7) 526-542
9. Blomme, B.; Van Steenkiste, C.; Callewaert, N.; Van Vlierberghe, H. Alteration of protein glycosylation in liver diseases J. Hepatol. 2009, 50 (3) 592-603
10. An, H. J.; Froehlich, J. W.; Lebrilla, C. B. Determination of glycosylation sites and site-specific heterogeneity in glycoproteins Curr. Opin. Chem. Biol. 2009, 13 (4) 421-426
11. Zaia, J. Mass spectrometry and the emerging field of glycomics Chem. Biol. 2008, 15 (9) 881-892
12. Mechref, Y.; Hu, Y.; Garcia, A.; Hussein, A. Identifying cancer biomarkers by mass spectrometry-based glycomics Electrophoresis 2012, 33 (12) 1755-1767
13. An, H. J.; Kronewitter, S. R.; de Leoz, M. L.; Lebrilla, C. B. Glycomics and disease markers Curr. Opin. Chem. Biol. 2009, 13 (5-6) 601-607
14. Ruhaak, L. R.; Miyamoto, S.; Lebrilla, C. B. Developments in the identification of glycan biomarkers for the detection of cancer Mol. Cell. Proteomics 2013, 12 (4) 846-855
15. Ressom, H. W.; Varghese, R. S.; Goldman, L.; Loffredo, C. A.; Abdel-Hamid, M.; Kyselova, Z.; Mechref, Y.; Novotny, M.; Goldman, R. Analysis of MALDI-TOF mass spectrometry data for detection of glycan biomarkers Pac. Symp. Biocomput. 2008, 216-227
16. Tang, Z.; Varghese, R. S.; Bekesova, S.; Loffredo, C. A.; Hamid, M. A.; Kyselova, Z.; Mechref, Y.; Novotny, M. V.; Goldman, R.; Ressom, H. W. Identification of N-glycan serum markers associated with hepatocellular carcinoma from mass spectrometry data J. Proteome Res. 2010, 9 (1) 104-112
17. Goldman, R.; Ressom, H. W.; Varghese, R. S.; Goldman, L.; Bascug, G.; Loffredo, C. A.; Abdel-Hamid, M.; Gouda, I.; Ezzat, S.; Kyselova, Z.; Mechref, Y.; Novotny, M. V. Detection of hepatocellular carcinoma using glycomic analysis Clin. Cancer Res. 2009, 15 (5) 1808-1813
18. Kamiyama, T.; Yokoo, H.; Furukawa, J.; Kurogochi, M.; Togashi, T.; Miura, N.; Nakanishi, K.; Kamachi, H.; Kakisaka, T.; Tsuruga, Y.; Fujiyoshi, M.; Taketomi, A.; Nishimura, S.; Todo, S. Identification of novel serum biomarkers of hepatocellular carcinoma using glycomic analysis Hepatology 2013, 57 (6) 2314-2325
19. Hu, Y.; Mechref, Y. Comparing MALDI-MS, RP-LC-MALDI-MS and RP-LC-ESI-MS glycomic profiles of permethylated N-glycans derived from model glycoproteins and human blood serum Electrophoresis 2012, 33 (12) 1768-1777
20. Desantos-Garcia, J. L.; Khalil, S. I.; Hussein, A.; Hu, Y.; Mechref, Y. Enhanced sensitivity of LC-MS analysis of permethylated N-glycans through online purification Electrophoresis 2011, 32 (24) 3516-3525
21. Picotti, P.; Rinner, O.; Stallmach, R.; Dautel, F.; Farrah, T.; Domon, B.; Wenschuh, H.; Aebersold, R. High-throughput generation of selected reaction-monitoring assays for proteins and proteomes Nat. Methods 2010, 7 (1) 43-46
22. Hu, Y.; Desantos-Garcia, J. L.; Mechref, Y. Comparative glycomic profiling of isotopically permethylated N-glycans by liquid chromatography/electrospray ionization mass spectrometry Rapid Commun. Mass Spectrom. 2013, 27 (8) 865-877
23. Huang, Y.; Mechref, Y.; Novotny, M. V. Microscale nonreductive release of O-linked glycans for subsequent analysis through MALDI mass spectrometry and capillary electrophoresis Anal. Chem. 2001, 73 (24) 6063-6069
24. Kang, P.; Mechref, Y.; Novotny, M. V. High-throughput solid-phase permethylation of glycans prior to mass spectrometry Rapid Commun. Mass Spectrom. 2008, 22 (5) 721-734
25. Mechref, Y.; Kang, P.; Novotny, M. V. Solid-phase permethylation for glycomic analysis Methods Mol. Biol. 2009, 53-64
26. Kang, P.; Mechref, Y.; Klouckova, I.; Novotny, M. V. Solid-phase permethylation of glycans for mass spectrometric analysis Rapid Commun. Mass Spectrom. 2005, 19 (23) 3421-3428
27. Jaitly, N.; Mayampurath, A.; Littlefield, K.; Adkins, J. N.; Anderson, G. A.; Smith, R. D. Decon2LS: An open-source software package for automated processing and visualization of high resolution mass spectrometry data BMC Bioinf. 2009, 10.1186/1471-2105-10-87
28. Voss, B.; Hanselmann, M.; Renard, B. Y.; Lindner, M. S.; Kothe, U.; Kirchner, M.; Hamprecht, F. SIMA: Simultaneous multiple alignment of LC/MS peak lists. A Bioinformatics 2011, 27 (7) 987-993
29. Tanabe, K.; Deguchi, A.; Higashi, M.; Usuki, H.; Suzuki, Y.; Uchimura, Y.; Kuriyama, S.; Ikenaka, K. Outer arm fucosylation of N-glycans increases in sera of hepatocellular carcinoma patients Biochem. Biophys. Res. Commun. 2008, 374 (2) 219-225
30. Liu, X. E.; Desmyter, L.; Gao, C. F.; Laroy, W.; Dewaele, S.; Vanhooren, V.; Wang, L.; Zhuang, H.; Callewaert, N.; Libert, C.; Contreras, R.; Chen, C. N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus Hepatology 2007, 46 (5) 1426-1435
31. Debruyne, E. N.; Vanderschaeghe, D.; Van Vlierberghe, H.; Vanhecke, A.; Callewaert, N.; Delanghe, J. R. Diagnostic value of the hemopexin N-glycan profile in hepatocellular carcinoma patients Clin. Chem. 2010, 56 (5) 823-831
32. Hashimoto, K.; Goto, S.; Kawano, S.; Aoki-Kinoshita, K. F.; Ueda, N.; Hamajima, M.; Kawasaki, T.; Kanehisa, M. KEGG as a glycome informatics resource Glycobiology 2006, 16 (5) 63R-70R
33. Benjamini, Y.; Hochberg, Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing Journal of the Royal Statistical Society. Series B (Methodological) 1995, 57 (1) 289-300
34. Mehta, A.; Norton, P.; Liang, H.; Comunale, M. A.; Wang, M.; Rodemich-Betesh, L.; Koszycki, A.; Noda, K.; Miyoshi, E.; Block, T. Increased levels of tetra-antennary N-linked glycan but not core fucosylation are associated with hepatocellular carcinoma tissue Cancer Epidemiol. Biomarkers Prev. 2012, 21 (6) 925-933
35. Zhao, Y.; Sato, Y.; Isaji, T.; Fukuda, T.; Matsumoto, A.; Miyoshi, E.; Gu, J.; Taniguchi, N. Branched N-glycans regulate the biological functions of integrins and cadherins FEBS J. 2008, 275 (9) 1939-1948
36. Pinho, S. S.; Reis, C. A.; Paredes, J.; Magalhaes, A. M.; Ferreira, A. C.; Figueiredo, J.; Xiaogang, W.; Carneiro, F.; Gartner, F.; Seruca, R. The role of N-acetylglucosaminyltransferase III and V in the post-transcriptional modifications of E-cadherin Hum. Mol. Genet. 2009, 18 (14) 2599-2608
37. Yao, M.; Zhou, D. P.; Jiang, S. M.; Wang, Q. H.; Zhou, X. D.; Tang, Z. Y.; Gu, J. X. Elevated activity of N-acetylglucosaminyltransferase V in human hepatocellular carcinoma J. Cancer Res. Clin. Oncol. 1998, 124 (1) 27-30
38. Zhao, Y.; Li, Y.; Ma, H.; Dong, W.; Zhou, H.; Song, X.; Zhang, J.; Jia, L. Modification of sialylation mediates the invasive properties and chemosensitivity of human hepatocellular carcinoma Mol. Cell. Proteomics 2014, 13 (2) 520-536
39. Pousset, D.; Piller, V.; Bureaud, N.; Monsigny, M.; Piller, F. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma Cancer Res. 1997, 57 (19) 4249-4256
40. Hedlund, M.; Ng, E.; Varki, A.; Varki, N. M. Alpha 2-6-linked sialic acids on N-glycans modulate carcinoma differentiation in vivo Cancer Res. 2008, 68 (2) 388-394
41. Subramanian, A.; Tamayo, P.; Mootha, V. K.; Mukherjee, S.; Ebert, B. L.; Gillette, M. A.; Paulovich, A.; Pomeroy, S. L.; Golub, T. R.; Lander, E. S.; Mesirov, J. P. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles Proc. Natl. Acad. Sci. U.S.A. 2005, 102 (43) 15545-15550